ConductScience.org, home

Gene · 11277

Papers2,317

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

141 to 160 of 2,317

Download this page as JSON
TitleJournalYearPMIDFound bySource
Total tanshinones ameliorates cGAS-STING-mediated inflammatory and autoimmune diseases by affecting STING-IRF3 binding.Chin Med202439148120PubTator, text miningPubMed
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations in conjunction with systemic lupus erythematosus: Missed diagnosis or misdiagnosis?Immun Inflamm Dis202439119967PubTator, text miningPubMed
The landscape of rare genetic variants in familial Waldenström macroglobulinemia.Blood Neoplasia202439036705PubTator, text miningPubMed
Augmentation of DNA exonuclease TREX1 in macrophages as a therapy for cardiac ischemic injury.bioRxiv202439026690PubTator, text miningPubMed
Graphene oxide-functionalized molecular beacon for real-time interference-free detection of Ki-67 mRNA in living cells.Talanta202439002264PubTator, text miningPubMed
Aicardi-Goutières Syndrome Type 1: A Novel Missense Variant and Review of the Mutational Spectrum.Iran J Child Neurol202438988838PubTator, text miningPubMed
Self-powered triboelectric-responsive microneedles with controllable release of optogenetically engineered extracellular vesicles for intervertebral disc degeneration repair.Nat Commun202438982049PubTator, text miningPubMed
Correction to: Mutations in the non-catalytic polyproline motif destabilize TREX1 and amplify cGAS-STING signaling.Hum Mol Genet202438979616PubTator, text miningPubMed
Deciphering the molecular landscape of ionising radiation-induced eye damage with the help of genomic data mining.Arh Hig Rada Toksikol202438963141PubTator, text miningPubMed
Crizanlizumab for retinal vasculopathy with cerebral leukoencephalopathy in a phase II clinical study.J Clin Invest202438950286PubTator, text miningPubMed
IFN-I Score and Rare Genetic Variants in Children with Systemic Lupus Erythematosus.Biomedicines202438927451PubTator, text miningPubMed
MRE11 and TREX1 control senescence by coordinating replication stress and interferon signaling.Nat Commun202438926338PubTator, text miningPubMed
PELI2 is a negative regulator of STING signaling that is dynamically repressed during viral infection.Mol Cell202438917796PubTator, text miningPubMed
Imbalance of the von Willebrand Factor - ADAMTS-13 axis in patients with retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S).Neurol Res Pract202438898536PubTator, text miningPubMed
Identification of the cytoplasmic DNA-Sensing cGAS-STING pathway-mediated gene signatures and molecular subtypes in prostate cancer.BMC Cancer202438877472PubTator, text miningPubMed
A phytomedicine extract exerts an anti-inflammatory response in the lungs by reducing STING-mediated type I interferon release.Phytomedicine202438850630PubTator, text miningPubMed
Three prime repair exonuclease 1 preferentially degrades the integration-incompetent HIV-1 DNA through favorable kinetics, thermodynamic, structural, and conformational properties.J Biol Chem202438838778PubTator, text miningPubMed
T-Rex escaped from the cytosolic park: Re-thinking the impact of TREX1 exonuclease deficiencies on genomic stability.Bioessays202438837436PubTator, text miningPubMed
Inherited C-terminal TREX1 variants disrupt homology-directed repair to cause senescence and DNA damage phenotypes in Drosophila, mice, and humans.Nat Commun202438824133PubTator, text miningPubMed
Mutations in the non-catalytic polyproline motif destabilize TREX1 and amplify cGAS-STING signaling.Hum Mol Genet202438796715PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/11277/papers?page=8